On June 29, 2022 ResMed Inc. entered into a certain Second Amended and Restated Credit Agreement, dated as of the Closing Date by and among ResMed, as borrower, each of the lenders identified therein, MUFG Union Bank, N.A., as administrative agent, joint lead arranger, sole book runner, swing line lender and letter of credit issuer, Westpac Banking Corporation, as syndication agent and joint lead arranger, HSBC Bank Australia Limited, as syndication agent and joint lead arranger, HSBC Bank USA, National Association, as syndication agent and joint lead arranger, and Wells Fargo Bank, National Association, as documentation agent. The Revolving Credit Agreement, among other things, provides ResMed a senior unsecured revolving credit facility (the "Revolving Credit Facility") in an aggregate amount of $1,500,000,000 USD or USD equivalents, with an uncommitted option to increase the Revolving Credit Facility by an additional amount equal to the greater of (x) $1,000,000,000 USD or USD equivalents, and (y) 1.00 times the EBITDA (as defined in the Revolving Credit Agreement) of ResMed and its subsidiaries on a consolidated basis for the trailing twelve-month measurement period. The Revolving Credit Facility amends and restates that certain Amended and Restated Credit Agreement, dated as of April 17, 2018, among ResMed, MUFG Union Bank, N.A., Westpac Banking Corporation and the lenders party thereto which provided ResMed with a senior unsecured revolving credit facility in an aggregate amount of $1,600,000,000 USD with an uncommitted option to increase such facility by an additional $300,000,000 USD.

ResMed's obligations under the Revolving Credit Agreement are guaranteed by certain ResMed direct and indirect U.S. subsidiaries, including Brightree LLC, Brightree Home Health & Hospice LLC, Brightree Patient Collections LLC, ResMed Digital Health Inc., ResMed Motor Technologies Inc., MatrixCare Inc., ResMed SAAS Holdings Inc., Reciprocal Labs Corporation, ResMed Operations Inc., HealthCareFirst Holding Company, HCF HoldCo Company, ResMed Corp., and HealthCareFirst Inc. (collectively, the "Revolving Facility Guarantors"), pursuant to a second amended and restated unconditional guaranty, dated as of the Closing Date (the "Revolving Facility Guaranty"), and related documents. The Revolving Credit Agreement terminates on June 29, 2027, when all unpaid principal and interest under the loans must be repaid. The outstanding principal amount due under the Revolving Credit Facility will bear interest at a rate equal to the Adjusted Term SOFR (as defined in the Revolving Credit Facility) plus 0.75% to 1.50% (depending on the then-applicable leverage ratio) or the Base Rate (as defined in the Revolving Credit Facility) plus 0.0% to 0.50% (depending on the then-applicable leverage ratio).

An applicable commitment fee of 0.075% to 0.150% (depending on the then-applicable leverage ratio) applies on the unused portion of the Revolving Credit Facility. Proceeds of loans under the Revolving Credit Agreement will be used for general corporate purposes. The Revolving Credit Agreement contains customary covenants, including a financial covenant which requires that ResMed maintain, on a consolidated basis, a maximum leverage ratio of funded debt to EBITDA (as defined in the Revolving Credit Agreement).

The entire principal amount of the Revolving Credit Facility and any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the Revolving Credit Agreement. Events of default under the Revolving Credit Agreement include failure to make payments when due, the occurrence of a default in the performance of any covenants in the Revolving Credit Agreement or related documents, or certain changes of control of ResMed, the Revolving Facility Guarantors, ResMed Pty Limited, ResMed Global Holdings Ltd. and/or ResMed Holdings Pty Ltd.